Literature DB >> 21765403

Protective HIV-specific CD8+ T cells evade Treg cell suppression.

Shokrollah Elahi1, Warren L Dinges, Nicholas Lejarcegui, Kerry J Laing, Ann C Collier, David M Koelle, M Juliana McElrath, Helen Horton.   

Abstract

Specific human leukocyte antigens (HLAs), notably HLA-B*27 and HLA-B*57 allele groups, have long been associated with control of HIV-1. Although the majority of HIV-specific CD8(+) T cells lose proliferative capacity during chronic infection, T cells restricted by HLA-B*27 or HLA-B*57 allele groups do not. Here we show that CD8(+) T cells restricted by 'protective' HLA allele groups are not suppressed by T(reg) cells, whereas, within the same individual, T cells restricted by 'nonprotective' alleles are highly suppressed ex vivo. This differential sensitivity of HIV-specific CD8(+) T cells to T(reg) cell-mediated suppression correlates with their expression of the inhibitory receptor T cell immunoglobulin domain and mucin domain 3 (Tim-3) after stimulation with their cognate epitopes. Furthermore, we show that HLA-B*27- and HLA-B*57-restricted effectors also evade T(reg) cell-mediated suppression by directly killing T(reg) cells they encounter in a granzyme B (GzmB)-dependent manner. This study uncovers a previously unknown explanation for why HLA-B*27 and HLA-B*57 allele groups are associated with delayed HIV-1 disease progression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21765403      PMCID: PMC3324980          DOI: 10.1038/nm.2422

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  41 in total

Review 1.  Cellular immune responses to HIV.

Authors:  A J McMichael; S L Rowland-Jones
Journal:  Nature       Date:  2001-04-19       Impact factor: 49.962

2.  Formation of HLA-B27 homodimers and their relationship to assembly kinetics.

Authors:  Antony N Antoniou; Stuart Ford; Joel D Taurog; Geoffrey W Butcher; Simon J Powis
Journal:  J Biol Chem       Date:  2003-12-18       Impact factor: 5.157

3.  HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors.

Authors:  Stephen A Migueles; Alisha C Laborico; W Lesley Shupert; M Shirin Sabbaghian; Ronald Rabin; Claire W Hallahan; Debbie Van Baarle; Stefan Kostense; Frank Miedema; Mary McLaughlin; Linda Ehler; Julia Metcalf; Shuying Liu; Mark Connors
Journal:  Nat Immunol       Date:  2002-10-07       Impact factor: 25.606

4.  Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance.

Authors:  Catherine A Sabatos; Sumone Chakravarti; Eugene Cha; Anna Schubart; Alberto Sánchez-Fueyo; Xin Xiao Zheng; Anthony J Coyle; Terry B Strom; Gordon J Freeman; Vijay K Kuchroo
Journal:  Nat Immunol       Date:  2003-10-12       Impact factor: 25.606

5.  Regulation of galectin-9 expression and release in Jurkat T cell line cells.

Authors:  Sophie Chabot; Yumiko Kashio; Masako Seki; Yukako Shirato; Kazuhiro Nakamura; Nozomu Nishi; Takanori Nakamura; Ryoji Matsumoto; Mitsuomi Hirashima
Journal:  Glycobiology       Date:  2002-02       Impact factor: 4.313

6.  Frequency and function of HIV-specific CD8(+) T cells.

Authors:  S A Migueles; M Connors
Journal:  Immunol Lett       Date:  2001-11-01       Impact factor: 3.685

Review 7.  The influence of HLA genotype on AIDS.

Authors:  Mary Carrington; Stephen J O'Brien
Journal:  Annu Rev Med       Date:  2001-12-03       Impact factor: 13.739

8.  Diversity in CD8(+) T cell function and epitope breadth among persons with genital herpes.

Authors:  Kerry J Laing; Amalia S Magaret; Dawn E Mueller; Lin Zhao; Christine Johnston; Stephen C De Rosa; David M Koelle; Anna Wald; Lawrence Corey
Journal:  J Clin Immunol       Date:  2010-07-16       Impact factor: 8.542

9.  Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells.

Authors:  Mathias Lichterfeld; Daniel E Kaufmann; Xu G Yu; Stanley K Mui; Marylyn M Addo; Mary N Johnston; Daniel Cohen; Gregory K Robbins; Eunice Pae; Galit Alter; Alysse Wurcel; David Stone; Eric S Rosenberg; Bruce D Walker; Marcus Altfeld
Journal:  J Exp Med       Date:  2004-09-20       Impact factor: 14.307

10.  Multiple Loci within the major histocompatibility complex confer risk of psoriasis.

Authors:  Bing-Jian Feng; Liang-Dan Sun; Razieh Soltani-Arabshahi; Anne M Bowcock; Rajan P Nair; Philip Stuart; James T Elder; Steven J Schrodi; Ann B Begovich; Gonçalo R Abecasis; Xue-Jun Zhang; Kristina P Callis-Duffin; Gerald G Krueger; David E Goldgar
Journal:  PLoS Genet       Date:  2009-08-14       Impact factor: 5.917

View more
  103 in total

1.  Regulatory T cell frequencies do not correlate with breadth or magnitude of HIV-1-specific T cell responses.

Authors:  Mathieu Angin; Hendrik Streeck; Fang Wen; Melanie King; Florencia Pereyra; Marcus Altfeld; Bruce D Walker; Marylyn M Addo
Journal:  AIDS Res Hum Retroviruses       Date:  2012-04-05       Impact factor: 2.205

2.  Elite controllers with low to absent effector CD8+ T cell responses maintain highly functional, broadly directed central memory responses.

Authors:  Zaza M Ndhlovu; Jacqueline Proudfoot; Kevin Cesa; Donna Marie Alvino; Ashley McMullen; Seanna Vine; Eleni Stampouloglou; Alicja Piechocka-Trocha; Bruce D Walker; Florencia Pereyra
Journal:  J Virol       Date:  2012-04-18       Impact factor: 5.103

3.  Effect of the use of Galectin-9 and blockade of TIM-3 receptor in the latent cellular reservoir of HIV-1.

Authors:  Marta Sanz; Nadia Madrid-Elena; Sergio Serrano-Villar; Alejandro Vallejo; Carolina Gutiérrez; Santiago Moreno
Journal:  J Virol       Date:  2020-12-23       Impact factor: 5.103

Review 4.  Association of HLA-alleles with the immune regulation of chronic viral infections.

Authors:  Shokrollah Elahi; Helen Horton
Journal:  Int J Biochem Cell Biol       Date:  2012-05-14       Impact factor: 5.085

5.  Engineering HIV-Resistant, Anti-HIV Chimeric Antigen Receptor T Cells.

Authors:  Malika Hale; Taylor Mesojednik; Guillermo S Romano Ibarra; Jaya Sahni; Alison Bernard; Karen Sommer; Andrew M Scharenberg; David J Rawlings; Thor A Wagner
Journal:  Mol Ther       Date:  2017-01-28       Impact factor: 11.454

6.  Both HLA-B*57 and plasma HIV RNA levels contribute to the HIV-specific CD8+ T cell response in HIV controllers.

Authors:  Camille Lécuroux; Asier Sáez-Cirión; Isabelle Girault; Pierre Versmisse; Faroudy Boufassa; Véronique Avettand-Fenoël; Christine Rouzioux; Laurence Meyer; Gianfranco Pancino; Olivier Lambotte; Martine Sinet; Alain Venet
Journal:  J Virol       Date:  2013-10-16       Impact factor: 5.103

7.  The same major histocompatibility complex polymorphism involved in control of HIV influences peptide binding in the mouse H-2Ld system.

Authors:  Samanthi Narayanan; David M Kranz
Journal:  J Biol Chem       Date:  2013-09-24       Impact factor: 5.157

8.  Factors Leading to the Loss of Natural Elite Control of HIV-1 Infection.

Authors:  María Pernas; Laura Tarancón-Diez; Cecilio Lopez-Galindez; Ezequiel Ruiz-Mateos; Esther Rodríguez-Gallego; Josep Gómez; Julia G Prado; Concepción Casado; Beatriz Dominguez-Molina; Isabel Olivares; Maite Coiras; Agathe León; Carmen Rodriguez; Jose Miguel Benito; Norma Rallón; Montserrat Plana; Onofre Martinez-Madrid; Marta Dapena; Jose Antonio Iribarren; Jorge Del Romero; Felipe García; José Alcamí; MaÁngeles Muñoz-Fernández; Francisco Vidal; Manuel Leal
Journal:  J Virol       Date:  2018-02-12       Impact factor: 5.103

9.  Metabolic pathway activation distinguishes transcriptional signatures of CD8+ T cells from HIV-1 elite controllers.

Authors:  Fatema Z Chowdhury; Zhengyu Ouyang; Maria Buzon; Bruce D Walker; Mathias Lichterfeld; Xu G Yu
Journal:  AIDS       Date:  2018-11-28       Impact factor: 4.177

10.  Early Gag immunodominance of the HIV-specific T-cell response during acute/early infection is associated with higher CD8+ T-cell antiviral activity and correlates with preservation of the CD4+ T-cell compartment.

Authors:  Gabriela Turk; Yanina Ghiglione; Juliana Falivene; María Eugenia Socias; Natalia Laufer; Romina Soledad Coloccini; Ana María Rodriguez; María Julia Ruiz; María Ángeles Pando; Luis David Giavedoni; Pedro Cahn; Omar Sued; Horacio Salomon; María Magdalena Gherardi
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.